Foley Hoag Represents Biogen in $1 Billion Credit Facility

Foley Hoag LLP advised Biogen Inc. (Nasdaq: BIIB), a global biotechnology company, in connection with its $1.0 billion senior unsecured revolving credit facility.

Biogen entered the credit deal with Bank of America NA — as administrative agent, swing line lender and the L/C issuer — as well as other lenders.

Based in Cambridge, MA, Biogen discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide.

Foley Hoag lawyers Thomas Draper, Anne Seymour and Matthew Burton represented Biogen in the transaction.